课题基金 / 基金详情

Novel immunohistochemistry-based predictive and prognostic tests for hormone receptor-positive breast cancer

Novel immunohistochemistry-based predictive and prognostic tests for hormone receptor-positive breast cancer
基于免疫组织化学的新型激素受体阳性乳腺癌预测和预后测试
批准号：
486311
负责人：
Kaur Amandeep
金额：
$1.27万
依托单位：
University of Winnipeg
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486311&lang=en
关键词：
Breast Cancer Chromatin Immuno Percipitation Endocrine Therapy Hormone Receptors Immunohistochemistry Metastatic Breast Cancer N-Myristoylation Nuclear Nmt Protein Oncoproteins Triple Negative Breast Cancer

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer has existed for millions of years, but even after billions of dollars in research, we haven’t found a solution that affects more than 14 million lives annually. Women account for 99% of breast cancer patients, while men account for only 1%. The lac
期刊论文(0)
专著(0)
科研奖励(0)
会议论文